Highland Capital Management (Texas)’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $880K | Hold |
13,855
| – | – | 0.05% | 185 |
|
|
2019
Q1 | $961K | Sell |
13,855
-3,200
| -19% | -$222K | 0.06% | 178 |
|
|
2018
Q4 | $742K | Hold |
17,055
| – | – | 0.06% | 174 |
|
|
2018
Q3 | $1.3M | Sell |
17,055
-2,400
| -12% | -$183K | 0.07% | 153 |
|
|
2018
Q2 | $1.5M | Sell |
19,455
-7,800
| -29% | -$600K | 0.08% | 139 |
|
|
2018
Q1 | $1.39M | Hold |
27,255
| – | – | 0.07% | 159 |
|
|
2017
Q4 | $1.26M | Sell |
27,255
-11,720
| -30% | -$544K | 0.06% | 137 |
|
|
2017
Q3 | $2.08M | Hold |
38,975
| – | – | 0.09% | 138 |
|
|
2017
Q2 | $2.42M | Hold |
38,975
| – | – | 0.1% | 131 |
|
|
2017
Q1 | $2.64M | Sell |
38,975
-2,275
| -6% | -$154K | 0.13% | 122 |
|
|
2016
Q4 | $2.9M | Sell |
41,250
-23,750
| -37% | -$1.67M | 0.14% | 119 |
|
|
2016
Q3 | $4.61M | Sell |
65,000
-26,500
| -29% | -$1.88M | 0.14% | 110 |
|
|
2016
Q2 | $4.48M | Buy |
+91,500
| New | +$4.48M | 0.18% | 104 |
|